Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

AM-643 is a candidate for topical treatment of skin disorders

Aug. 11, 2010

Vicept presents clinical data on V-101 in rosacea-associated erythema

Aug. 6, 2010

EXC-001 reduces scar severity after abdominoplasty surgery in phase II trial

Aug. 5, 2010

Taisho Pharma discontinues development of TS-022 for atopic dermatitis with pruritus

Aug. 4, 2010

Results reported on Basilea's Toctino in severe chronic hand eczema

Aug. 3, 2010

NovaBay's NVC-422 is safe and efficacious against impetigo in phase II trial

July 26, 2010

FDA approves Veltin gel for acne vulgaris in patients age 12 years and older

July 20, 2010

Biolipox presents novel PDE4/PDE7 inhibitors

July 19, 2010

Clinuvel reports on phase III trial of Scenesse in EPP

July 13, 2010

Fibrocell reports full enrollment in histology trial of azficel-T

July 12, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...